BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 653309)

  • 1. Immunological family studies in Hodgkin's disease. Is the immunodeficiency horizontally transmitted?
    Björkholm M; Holm G; Mellstedt H
    Scand J Haematol; 1978 Apr; 20(4):297-305. PubMed ID: 653309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological defects in healthy twin siblings to patients with Hodgkin's disease.
    Björkholm M; Holm G; De Faire U; Mellsted H
    Scand J Haematol; 1977 Oct; 19(4):396-404. PubMed ID: 562530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic profile of patients with cured Hodgkin's disease.
    Bjorkholm M; Holm G; Mellstedt H
    Scand J Haematol; 1977 May; 18(5):361-8. PubMed ID: 141726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune deficiency in family members of patients with Hodgkin's disease.
    Merk K; Björkholm M; Tullgren O; Mellstedt H; Holm G
    Cancer; 1990 Nov; 66(9):1938-43. PubMed ID: 2224790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen induced blood lymphocyte DNA synthesis as a prognostic indicator in patients with non-Hodgkin's lymphomas in clinical remission.
    Lindemalm CS; Björkholm M; Holm G; Johansson B; Mellstedt H
    Acta Radiol Oncol; 1983; 22(6):455-9. PubMed ID: 6328876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative and functional abnormalities of total T lymphocytes in relatives of patients with Hodgkin's disease.
    del Giacco GS; Cengiarotti L; Mantovani G; Murgia M; Broccia G; Corda G; di Tucci A
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):793-801. PubMed ID: 3876218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and immunopathological findings in a lymphoma family.
    Lynch HT; Marcus JN; Weisenburger DD; Watson P; Fitzsimmons ML; Grierson H; Smith DM; Lynch J; Purtilo D
    Br J Cancer; 1989 Apr; 59(4):622-6. PubMed ID: 2713249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood lymphocyte functions in relation to splenic weight and tumor involvement in untreated Hodgkin's disease.
    Björkholm M; Askergren J; Wedelin C; Holm G; Mellstedt H
    Scand J Haematol; 1980 Jul; 25(1):51-7. PubMed ID: 6969422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-deficiency in Hodgkin's disease (HD): a study of patients and healthy relatives in families with multiple cases.
    Cimino G; Lo Coco F; Cartoni C; Gallerano T; Luciani M; Lopez M; De Rossi G
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1595-601. PubMed ID: 2974806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Baral E; Blomgren H; Juhlin I
    Cancer; 1979 Oct; 44(4):1241-6. PubMed ID: 498012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease.
    Holm G; Björkholm M; Mellstedt H; Nilsson P
    J Clin Lab Immunol; 1982 Jan; 7(1):51-4. PubMed ID: 6461767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease.
    Björkholm M; Wedelin C; Holm G; Johansson B; Mellstedt H
    Cancer; 1981 Nov; 48(9):2010-5. PubMed ID: 7296509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunodeficiency and prognosis in Hodgkin's disease.
    Björkholm M; Holm G; Mellstedt H; Johansson B
    Acta Med Scand; 1975 Oct; 198(4):275-9. PubMed ID: 1081328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
    Björkholm M; Holm G; Askergren J; Mellstedt H
    Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous and Concanavalin A-induced suppressor activity in control and Hodgkin's disease patients.
    Akbar AN; Jones DB; Wright DH
    Br J Cancer; 1984 Mar; 49(3):349-56. PubMed ID: 6231045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of HL-A antigen phenotypes and lymphocyte abnormalities in Hodgkin's disease.
    Björkholm M; Holm G; Johansson B; Mellstedt H; Möller E
    Tissue Antigens; 1975 Oct; 6(4):247-56. PubMed ID: 1081776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte abnormalities in untreated patients with Hodgkin's disease.
    Holm G; Mellstedt H; Björkholm M; Johansson B; Killander D; Sundblad R; Söderberg G
    Cancer; 1976 Feb; 37(2):751-62. PubMed ID: 1082795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.